NOROCLOX DC, intramaminė suspensija, galvijams
NOROCLOX DC, intramaminė suspensija, galvijams
Authorised
- Cloxacillin
Product identification
Medicine name:
NOROCLOX DC, intramaminė suspensija, galvijams
Active substance:
- Cloxacillin
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin500.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Milk96hourAfter calving
-
Milk32dayIf calved less than 28 days after the last treatment.
-
Milk42dayDue to careless treatment of cows during lactation.
-
Meat and offal28dayDue to careless treatment of cows during lactation.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/97/0432/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/06/2026
